Tag Archives: law

Substances of Human Origin (or SoHO): the New EU Regulation

PURPOSE OF THE NEW REGULATION. On June 13, 2024, the European Parliament and the Council adopted a new regulation on the substances of human origin (so-called SoHO), repealing Directives 2002/98/EC and 2004/23/EC. The new regulation:

  • was necessary because previous directives only partially managed to harmonize member states’ legislation on cells, tissues and blood; also, a new definition of SoHO was needed;
  • introduces mechanisms to grant continuity and resilience of SoHO supplies and to facilitate EU cross border exchanges and access to SoHO;
  • enhances safety of donors and recipients (included the offspring born from medical assisted procreation).

WHAT IS A ‘SOHO’? A SoHO is now defined as “any substance collected from the human body, whether or not it contains cells and whether or not those cells are alive, including SoHO preparations resulting from the processing of the above-mentioned substance”. The definition has been expanded to include breast milk and gut microbiota, as well as blood preparations different from those used for transfusions. Any future SoHO will be automatically included in the regulation. The regulation also defines SoHO preparation as a SoHO subjected to processing, with a specific clinical indication, intended for human application on a recipient or for distribution.

WHO DEALS WITH SOHO? The regulation also defines which will be the main actors in the organizational chain from SoHO donation to application. Specifically:

  • A SoHO entity is a legal entity established in the EU that carries out SoHO-related activities (e.g. collection, processing, control, storage, release, distribution, import, export, application on human beings,  clinical studies and outcomes recording on SoHO preparations)
  • A SoHO establishment is a SoHo entity that carries out one of the following SoHO-related activities: A) both processing and storage; B) release; C) import; D) export;
  • Competent authorities for SoHO are appointed by each member state and 1) maintain SoHO entities’ registry, 2) deal with authorization process for SoHO establishments and SoHO preparations 3) carry out inspections and evaluate plans for monitoring clinical outcomes.

WHEN?  The regulation will be enforceable by mid-2027.

TAKEAWAYS. Apparently, it is science-friendly as the definition of SoHO will be broader and more flexible than before. Also, in view of its structure, there is hope that it will succeed in ensuring more uniformity and granting an enhanced minimum level of safety across EU.

New Guidelines on Web Scraping

Pursuant to Article 57(1)(b) of the GDPR, on May 20, 2024 the Italian Data Protection Authority (“Italian DPA”) adopted guidelines [LINK] on web scraping, with the aim of providing guidance to operators of websites and online platforms, acting in Italy as data controllers of personal data made available online to the public.

Web scraping is defined by the Italian DPA as the massive collection of personal data from the web for the purpose of training generative artificial intelligence models. Specifically, whenever such phenomenon involves the collection of traceable information – linked to an identified or identifiable natural person – a data protection issue arises with reference to the identification of an appropriate legal basis for the processing of such data.

According to the guidelines, the assessment of the lawfulness of web scraping must be carried out on a case-by-case basis. Personal data are made available on the web as a result of a primary level processing by operators of online platforms as data controllers. Only then, third parties – often web robots or “bots” – may gather such data for different purposes while scraping the web. This is the reason why the Italian DPA addresses its guidelines to operators of online platforms: they are, in fact, the only ones able i) to more easily evaluate how data are used after being scraped from their platforms and ii) to implement measures on their platforms that may prevent or mitigate web scraping activity for purposes of training algorithms.

Possible precautions or enforcement actions identified by the Italian DPA are the following:

  • Creation of restricted areas, which can only be accessed after registration. In this way, certain personal data would be removed from public availability;
  • Inclusion of ad hoc clauses in the terms of service of the online platform expressly prohibiting the use of web scraping techniques;
  • Monitoring network traffic to detect any abnormal flow of data and adopting limits as countermeasures;
  • Direct intervention on bots (e.g. insertion on websites of CAPTCHA checks or monitoring log files to block undesirable users).  

Such measures should be adopted by the data controller after an independent assessment – in compliance with the accountability principle, which increasingly appears to govern new data protection legislation and strategies. At any rate, the Italian DPA acknowledges that, albeit useful, none of these measures can be expected to entirely prevent web scraping from happening.  

Processing Health Data: the Most Recent Amendment to Italian Privacy Code

The Italian “Privacy Code” (Legislative Decree No. 196/2003), which governs data protection in Italy together with the European GDPR, has recently been amended.

Law No. 56/2024, further implementing the National Recovery and Resilience Plan, intervened on section 110 of the Privacy Code, which deals with the processing of health-related data for the purposes of medical, biomedical or epidemiological scientific research.

Section 110 provides that consent of the data subject for the processing of health-related data for the purpose of medical, biomedical or epidemiological scientific research is not required when:

  • the research is carried out on the basis of legal provisions or European Union law, when processing is necessary for scientific research or statistical purposes, provided that an impact assessment is carried out pursuant to sections 35 and 36 of the GDPR; or
  • informing the data subject is impossible or involves a disproportionate effort, or would render impossible or seriously jeopardise the attainment of the purposes of the research.

In such cases – before the latest amendment – the data controller had to:

1) take appropriate measures to protect the rights, freedoms and interests of the data subject;

2) obtain a favorable opinion of the competent ethics committee; and

3) consult the Italian Data Protection Authority prior to processing.

The obligation to consult the Italian Data Protection Authority has now been repealed. Thus, there is no need to apply for the Authority’s clearance prior to processing health-related data (in those cases where consent of the data subject is not required under section 110 of the Privacy Code). 

This amendment may have a significant impact especially on retrospective studies for which informing data subjects is particularly burdensome. The data controller will, in fact, be able to proceed without the Authority’s permission. Nonetheless, the data controller will still have to comply with specific guarantees and ethical rules issued by the Authority – as specified by the amended section 110.

On the one hand, the amended section 110 seems to favor accountability and to soften the procedural requirements in processing health data for research purposes, making the overall procedure quicker. When it comes to “secondary use” of health data, the accountability approach should be considered strong enough to protect data and favorably welcomed, as it moves in the same direction of the European Health Data Space – which intends to provide a reliable and efficient system for the re-use of health data in areas as research and innovation.

On the other hand, though, the Italian Data Protection Authority has already issued some interim guarantees, specifying that data controllers – when processing health data related to deceased or non-contact subjects – must carry out and publish an impact assessment, pursuant to section 35 of the GDPR, notifying it to the Authority. It remains to be seen how the amendment will be handled by the Authority in practice: the effects of the simplification provided by the new version of section 110 may be diminished if the guarantees set forth by the Authority generate equally articulate procedures.      

Processing of personal and health data through apps and online platforms aimed at connecting HCPs and patients: the new digest of the Italian DPA

On March 2024, the Italian Data Protection Authority (“Italian DPA”) has issued a new digest (“Digest”) relating to the processing of personal data, whether or not concerning health data pursuant to section 9 of the GDPR, carried out through the utilization of platforms, accessible through apps or web pages (“Platforms”), that aim to facilitate connection between healthcare professionals (“HCPs”) and patients.

The use of such Platforms poses high risks to the protection and security of patients’ personal data, and in particular health-related data, given that the latter are subject to an enhanced protection regime set forth by section 9 of the GDPR. 

The Digest seeks to summarize the applicable data protection rules that may be followed, and defines the roles of the parties, as well as the legal bases, applicable to (i) the processing of personal data of the users by Platform’s owners; (ii) the processing of HCP’s personal data by Platform’s owners; and (iii) the processing of health data of the patients by the Platform’s owner and by the HCPs.

Additional guidance is provided as to:

  • The necessity for the Platform’s owner to carry out (and periodically update) a data protection impact assessment (DPIA) pursuant to section 35 GDPR, since the use of Platforms determine a “high risk” processing of personal data, as such kind of treatment automatically meets the criteria issued by the European Data Protection Board for the identification of the list of data processing that may be deemed subject to the duty to perform a DPIA;
  • Which information notices should be provided, by who and to whom, as well as the contents that such information notices should have in each case, according to sections 13 and 14 GDPR;
  • The specific rules applicable to cross-border data transfers and data transfer to third countries.

Lastly, the Digest includes a list of the most common measures that are taken by the data controllers to ensure an appropriate level of technical and organizational measures to meet the GDPR requirements, such as encryption, verification of the qualification of the HCPs that seek to enroll within the Platform; strengthened authentication systems, monitoring systems aimed at preventing unauthorized access or loss of data.

The Digest should be very welcomed by the Platform’s owners, as it now gives a reliable and complete legal frame that may be followed in order to set up a Platform in a way which is compliant with the GDPR principles.

Corporate Liability Under Legislative Decree No. 231/2001: Latest Developments

In the context of criminal proceedings for aggravated fraud for obtaining public funds (art. 640 bis of the Criminal Code) and for ideological falsity of the private party in a public deed (art. 483 of the Criminal Code), the Italian Supreme Court (ruling No. 3196/2024 Jan. 26, 2024) had the opportunity to reiterate some useful principles in the context of 231 Models:

the legal representative of the entity, suspected or accused of the predicate offense, cannot appoint the entity’s defense attorney, due to the absolute prohibition of representation posed by Article 39 of Legislative Decree No. 231 of 2001. The incompatible representative cannot perform any defensive act in the interest of the entity and, if performed, must be considered ineffective. However, the entity may join the proceedings by replacing the representative who has become incompatible or by appointing an ad hoc representative.

•The Court must always make an independent determination of the administrative liability of the entity and this means that:

1)It is not necessary to make a final and complete finding of individual criminal liability of the natural person, but a mere incidental finding is sufficient.

2)The configurability of criminal liability of managers for 231 crimes is not sufficient to affirm the liability of the entity. The judge must carry out a judgment of the suitability of the 231 Model adopted, ideally placing it at the time when the offence was committed, in order to verify whether compliance with the 231 Model would have eliminated or reduced the danger of the occurrence of offences of the same kind as the one that occurred.

The Data Act: a New European Regulation on Data Sharing in the EU

Today, January 11, 2024, marks the entry into force of EU Regulation 2023/2854, better known as “Data Act”.

The new regulation sets forth new rules on B2B and B2C data access and provides a regulatory framework for sharing data generated by the use of connected devices and related services. In addition, the Data Act contains measures to restrain economic operators from abusing contractual imbalances in data-sharing contracts.

The new regulation’s declared goals are to:

  • stimulate a competitive and fair data market;
  • foster data-driven innovation;
  • boost data accessibility;
  • make it easier to switch between data processing service providers;
  • protect data from unlawful transfers;
  • develop interoperability standards for data to be reused between sectors.

Art. 50 of the regulation provides that the new set of rules shall apply from September 12, 2025; however, certain articles, shall apply at a later stage.

Implementation of the “231” Compliance Model in the Pharma Industry: New Guidelines issued by the Italian Association of Pharmaceutical Companies

On September 5, 2023, the Italian Association of Pharmaceutical Companies (“Farmindustria” – https://www.farmindustria.it/) has issued guidelines to design an organizational model pursuant to the Legislative Decree 231/2001 in the pharmaceutical sector (“Guidelines”).

In particular, the Guidelines, by taking into account the main peculiarities of the pharma industry, seek to identify the typical activities that are most at risk for the commission of criminal offences, and provide detailed guidance about the main policies and preventive actions that should be carried out by companies in order to prevent their commission.

As expected, the highest risks concern relationships with public officials, which may lead to crimes such as corruption or fraud against the State, with significant advantages for pharma companies.

The Guidelines seek to drive the attention of companies involved in the pharma sector on the risks that are latent in the following areas:

  • Relationships with healthcare professionals (“HCP”) and healthcare organizations (“HCO”): compliance programs should regulate activities of the key account managers and their bonuses, sponsorship of congresses, grants and donations to HCOs, gifts to HCPs, as well as other sponsorship or advertisement activities;
  • Relationships with Public Authorities: many interactions with public officials may entail corruptions risks, such as, e.g., obtainment of Market Authorizations, price reimbursement negotiations with the Italian drug regulatory agency (AIFA – https://www.aifa.gov.it/), management of site visits and inspections, participation and execution of public tenders for the supply of drugs to HCOs;
  • Relationships with private entities: relationships with suppliers providing services in the context of clinical studies, pharmacies, patient advocacy organizations, patients and “expert patients”, or management of patient support programs also need to be regulated.

The Guidelines also offer a complete set of policies and other preventive remedies that may be sufficient to prevent the envisaged criminal risks.

The Guidelines are a useful tool for pharma companies and no similar initiatives have been taken by other associations with regard to different industries and sectors. The Guidelines also constitute a benchmark for best practices that will be difficult to ignore.

Do you need help in designing or updating your company’s “231” compliance model? Do not hesitate to reach out!

Italy – At Last – Implemented the Registry of UBOs (Ultimate Beneficial Owners)

All legal entities established in Italy are affected by the new regulation, which provides for a December 11, 2023 deadline.

The register of ultimate beneficial owners has been established and has become
operational also in Italy, after several extensions and delays. In fact, on October 9,
2023, the decree certifying the operation of the system for the communication of
data and information on beneficial ownership was published in the Official Gazette.

This last decree, which completes the implementation of anti-money laundering
legislation, triggers the obligation for all companies, private legal entities
(associations, foundations and other institutions of a private nature with legal
personality) and trusts to communicate data and information relating to their
beneficial ownership.

The communication on beneficial ownership must be made to the Companies’
Registry at the territorially competent Chamber of Commerce by and no later than
December 11, 2023, using exclusively electronic methods. With regard to
companies, the communication must be digitally signed by a director, without the
possibility to delegate such task. Therefore, directors who do not yet have a digital
signature device will need to obtain one.

Subsequently, legal entities shall notify any change in their beneficial ownership
within 30 days of the occurrence of the change. In addition, on an annual basis (and
in any case within 12 months from the first communication), the beneficial
ownership shall be confirmed: for companies this may take place on the occasion
of the annual filing of the financial statements.

For more information on the new requirements, check out our Client Alert here or reach out to us directly.

GDPR Cross-Border Complaints: a New Regulation Proposal Attempts to Harmonize the Procedural Rules Among the Member States

On July 4, 2023, the European Commission has issued a proposal for a new EU regulation laying down additional procedural rules aimed at ensuring a better and uniform enforcement of the GDPR among the Member States, especially with regard to the handling of cross-border complaints (“Proposal”).

The Proposal has been inspired by the findings of the reports issued by the European Commission and the European Data Protection Board concerning the status of the application of the GDPR among the Member States. Such reports stressed the need to make the handling of cross-border complaints more efficient and levelled across the EU, since the proceedings followed by local data protection authorities (“LDPA”) have been found to be differently designed and may thus lead to different application of the GDPR provisions.

The main features of the Proposal may be summarized as follows:

  • Submission and handling of cross-border complaints: The Proposal aims at removing the existing differences among the procedural rules applied by different LDPAs, namely with regard to how complaints on cross-boarder issues should be filed and which contents they should have. In such respect, a template for the filing of cross-border complaints – including a standard pre-determined set of information to be provided – has been drafted. The Proposal further specifies procedural rules for the rejection of complaints in cross-border cases and clarifies the roles and rights of the lead LDPA and of any other concerned LDPAs. A system of amicable settlement of complaints is also encouraged.
  • Procedural rights of parties under investigation: The Proposal further aims at harmonizing and strengthening the rights of defence in the course of cross-border investigations and proceedings. Specifically, the Proposal recognizes an extended right of the parties to be heard at key stages of the proceedings and imposes the creation of an administrative file and the parties’ rights of access to it.
  • Tools for cooperation between LDPAs: New tools have been designed to ease the building of consensus between the involved LDPAs on the main features of cross-border proceedings since their preliminary phase, in order to limit the recourse to the (time consuming) dispute resolution mechanism provided by section 65 GDPR only in few exceptional cases. LDPAs that are called to handle a cross-border complaint are required to provide other involved LDPAs with a summary of key issues”, wherethe main findings of facts and legal grounds underlying each complaint are set out. Concerned LDPAs will be able to provide their views on such summary and to raise “relevant and reasoned objections”, in which case a specific fast-track procedure is designed in order to ensure that disagreements among LDPAs are settled at the beginning of the process.
  • Acceleration of cross-border proceedings: Lastly, the Proposal, by imposing strict deadlines, aims to prevent undue delays within the proceedings.

At the moment it is still unclear whether the Proposal will be officially adopted and become a binding regulation. Certainly, it has been welcomed by the European Data Protection Board and by the European Data Protection Supervisor and may be a good opportunity to level the difference among Member States and make the proceedings more efficient.

GARANTE VS. CHATGPT: LATEST DEVELOPMENTS

1. An Order to Stop ChatGPT

On March 30, 2023 the Italian Data Protection Authority (“Garante”) issued an order by which it temporarily banned the ChatGPT platform (“ChatGPT”) operated by OpenAI LLC (“OpenAI”). The Garante in fact regards ChatGPT as infringing Articles 5, 6, 8, 13 and 25 of the GDPR. In particular:

  • No Information.  OpenAI does not provide any information to users, whose data is collected by OpenAI and processed via ChatGPT;
  • No Legal Basis.  There is no appropriate legal basis in relation to the collection of personal data and their processing for the purpose of training the algorithms underlying the operation of ChatGPT;
  • No Check of User’s Age.  OpenAI does not foresee any verification of users’ age in relation to the ChatGPT service, nor any filters prohibiting the use for users aged under 13.

Given that, the Garante has immediately banned the use of ChatGPT, and OpenAI has blocked the access to ChatGPT to the Italian people.

2. Measures Offered by OpenAI

On April 11, 2023, in light of the willingness expressed by OpenAI to put in place measures to protect the rights and the freedom of the users of ChatGPT, the Garante issued a new order, which opened the possibly to re-assess ChatGPT if OpenAI adopts the following measures:

  1. to draft and publish an information notice to data subjects, which should be linked so that it can be read before the registration;
  2. to make available, at least to data subjects who are connected from Italy, a tool to exercise their right to (i) object, (ii) obtain a rectification, insofar as such data have been obtained from third parties, or (iii) the erasure of their personal data;
  3. to change the legal basis of the processing of users’ personal data for the purpose of algorithmic training, by removing any reference to contract and instead relying on consent or legitimate interest;
  4. to include a request to all users connecting from Italy to go through an “age gate” and to submit a plan for the deployment of age verification tools; and
  5. to promote a non-marketing-oriented information campaign by May 15, 2023 on all the main Italian mass media, the content of which shall be agreed upon with the Italian Authority.

OpenAI has until April 30, 2023 to comply (until May 31, 2023 to prepare a plan for age verification tools). The objections by the Garante have been echoed by other European Union data protection authorities. The European Data Protection Board will be attempting to solve the dispute within two months and launched a dedicated task force on ChatGPT “to exchange information on possible enforcement actions conducted by data protection authorities”